Duration of smoking cessation is negatively associated with the magnitude of chronic prostatic inflammation and storage dysfunction in patients with benign prostatic hyperplasia
- 24 July 2020
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 27 (10) , 874-881
Abstract
Objectives To evaluate the impact of smoking and the benefit of smoking cessation on lower urinary tract function and prostatic inflammation in patients with benign prostatic hyperplasia. Methods The medical records of 118 benign prostatic hyperplasia patients who underwent transurethral prostatic surgery between 2006 and 2016 were analyzed. Their smoking history was confirmed. The relationship between smoking and main clinical parameters, International Prostate Symptom Scores, uroflowmetry, pressure flow study, magnitude of prostatic inflammation and the level of serum C‐reactive protein was investigated. Furthermore, the relationships between smoking cessation and these clinical parameters were assessed. Results The International Prostate Symptom Scores for straining among the non‐smokers were significantly lower than those of the smokers (1.71 vs 2.60, P = 0.029). In the pressure flow study, there were negative correlations between the duration of smoking and strong desire to void (correlation coefficient −0.314, P = 0.013), urgency (correlation coefficient −0.349, P = 0.008) and bladder volume at initial detrusor overactivity (correlation coefficient −0.417, P = 0.021). The duration of smoking cessation was negatively correlated with the magnitude of chronic prostatic inflammation (correlation coefficient −0.253, P = 0.027). In the pressure flow study, the duration of smoking cessation was positively correlated with urgency (correlation coefficient 0.286, P = 0.030) and maximum cystometric capacity (correlation coefficient 0.241, P = 0.050). Conclusions Smoking could be a risk factor for the exacerbation of storage dysfunction in benign prostatic hyperplasia patients. Smoking cessation is effective in improving chronic prostatic inflammation and storage dysfunction.Keywords
This publication has 27 references indexed in Scilit:
- Cardiovascular toxicity of nicotine: Implications for electronic cigarette useTrends in Cardiovascular Medicine, 2016
- Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking historyInternational Journal of Chronic Obstructive Pulmonary Disease, 2015
- Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivoNature Medicine, 2015
- The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation supportThe Lancet Oncology, 2014
- 21st-Century Hazards of Smoking and Benefits of Cessation in the United StatesNew England Journal of Medicine, 2013
- Signaling effectors underlying pathologic growth and remodeling of the heartJournal of Clinical Investigation, 2013
- Avoidable global cancer deaths and total deaths from smokingNature Reviews Cancer, 2009
- Nocturia and associated morbidity in a Danish population of men and women aged 60–80 yearsBJU International, 2008
- Risk behaviours and benign prostatic hyperplasiaBJU International, 2004
- Prevalence of and risk factors for nocturia: Analysis of a health screening programInternational Journal of Urology, 2004